Xu RH - Search Results

1

Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial.

Mai HQ, Chen QY, Chen D, Hu C, Yang K, Wen J, Li J, Shi YR, Jin F, Xu R, Pan J, Qu S, Li P, Hu C, Liu YC, Jiang Y, He X, Wang HM, Lim WT, Liao W, He X, Chen X, Liu Z, Yuan X, Li Q, Lin X, Jing S, Chen Y, Lu Y, Hsieh CY, Yang MH, Yen CJ, Samol J, Feng H, Yao S, Keegan P, Xu RH. Mai HQ, et al. Among authors: xu r, xu rh. Nat Med. 2021 Sep;27(9):1536-1543. doi: 10.1038/s41591-021-01444-0. Epub 2021 Aug 2. Nat Med. 2021. PMID: 34341578 Clinical Trial.

2

[Phase II clinical trial of oxaliplatin alone for refractory advanced colorectal cancer].

Xu RH, Guan ZZ, Feng FY, He XH, Liu SJ, Di LJ, Li SF, Li LQ. Xu RH, et al. Ai Zheng. 2003 Aug;22(8):874-6. Ai Zheng. 2003. PMID: 12917039 Clinical Trial. Chinese.

3

[Phase II clinical trial of home-produced Nedaplatin in treating advanced esophageal carcinoma].

Xu RH, Shi YX, Guan ZZ, Jiang WQ, Huang H, Ma ZY, Wang JH, Hu XH, Xie WM, Li XG, Liu YL, Pan LX, Dai AD, Zhuang W, Zhang C. Xu RH, et al. Ai Zheng. 2006 Dec;25(12):1565-8. Ai Zheng. 2006. PMID: 17166388 Clinical Trial. Chinese.

4

[Efficacy of gemcitabine combined oxaliplatin on advanced pancreatic cancer].

Shi YX, Xu RH, Jiang WQ, Zhang L, Lin TY, Li YH, Xia ZJ, Luo HY, Han B, Wang F, He YJ, Guan ZZ. Shi YX, et al. Among authors: xu rh. Ai Zheng. 2007 Dec;26(12):1381-4. Ai Zheng. 2007. PMID: 18076807 Free article. Chinese.

5

A pilot study of oxaliplatin, fluorouracil and folinic acid (FOLFOX-6) as first-line chemotherapy in advanced or recurrent gastric cancer.

Luo HY, Xu RH, Zhang L, Li YH, Shi YX, Lin TY, Han B, Wang F, Qiu MZ, He YJ, Guan ZZ. Luo HY, et al. Among authors: xu rh. Chemotherapy. 2008;54(3):228-35. doi: 10.1159/000140467. Epub 2008 Jun 18. Chemotherapy. 2008. PMID: 18560231 Clinical Trial.

6

[Progression in palliative chemotherapy for advanced colorectal cancer].

Xu RH, Qiu MZ. Xu RH, et al. Ai Zheng. 2008 Jun;27(6):661-6. Ai Zheng. 2008. PMID: 18570745 Free article. Review. Chinese.

7

Prognostic value of serum CA19-9 in patients with advanced pancreatic cancer receiving gemcitabine based chemotherapy.

An X, Li YH, Lin XB, Wang FH, Feng F, Xu RH, Jiang WQ, He YJ. An X, et al. Among authors: xu rh. Ai Zheng. 2009 Mar;28(3):286-91. Ai Zheng. 2009. PMID: 19619444 Free article.

8

[Efficacy of FORFIRI regimen on oxaliplatin-based chemotherapy-failed advanced colorectal cancer].

Li YH, Wang FH, Zhang DS, Wang ZQ, Feng F, Zhang L, Xu RH, Jiang WQ, He YJ. Li YH, et al. Among authors: xu rh. Ai Zheng. 2009 Sep;28(9):913-8. doi: 10.5732/cjc.008.10571. Ai Zheng. 2009. PMID: 19728906 Free article. Clinical Trial. Chinese.

9

Phase II study of capecitabine plus oxaliplatin (XELOX) as first-line treatment and followed by maintenance of capecitabine in patients with metastatic colorectal cancer.

Li YH, Luo HY, Wang FH, Wang ZQ, Qiu MZ, Shi YX, Xiang XJ, Chen XQ, He YJ, Xu RH. Li YH, et al. Among authors: xu rh. J Cancer Res Clin Oncol. 2010 Apr;136(4):503-10. doi: 10.1007/s00432-009-0682-5. Epub 2009 Sep 24. J Cancer Res Clin Oncol. 2010. PMID: 19777259 Clinical Trial.

10

[Progress in chemotherapy for advanced gastric cancer].

Xu RH, Teng KY. Xu RH, et al. Ai Zheng. 2009 Oct;28(10):1108-13. doi: 10.5732/cjc.008.10560. Ai Zheng. 2009. PMID: 19799823 Free article. Review. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

746 results

Search Page

Filters